지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
Objectives: This study aimed to ascertain what should be considered in the “Guideline for Clinical Trials with Herbal Medicinal Products for Colorectal Cancer” by analyzing the existing guidelines and clinical trials.
Methods: The development committee searched guidelines for herbal medicinal products for colorectal cancer that have already been developed. Then, clinical trials for colorectal cancer using herbal medicine were searched. The searched trials were analyzed in terms of inclusion and exclusion of participants, intervention, comparator, outcomes and trial design. Then, we compared the results of our analysis with the regulations and guidelines of the Ministry of Food and Drug Safety in order to identify the issues we will have to consider when making the “Guideline for Clinical Trials with Herbal Medicinal Products for Colorectal Cancer”. Several guidelines for anti-tumor agents and clinical trials with herbal medicinal products were searched on the national institution homepage. In addition, 12 articles were searched using a combination of the following search terms: ‘colorectal neoplasms", "herbal medicine’, "Medicine, Korean traditional", ‘Medicine, Chinese Traditional", ‘medicine, East Asian medicine’, ‘medicine, Kampo’, etc.
Results: The characteristics of participants were various, such as people with medical histories of surgeries or recurrent cancers or who complained of chemotherapy-induced side effects. The types of interventions were also various and included decoctions, powders, intravenous fluids, intraperitoneal injections and gargles. Comparators used included placebos and conventional treatments. The outcome measurements used in the studies were quality of life, symptom score, tumor response, and survival duration, etc. Safety was evaluated by recording adverse events.
Conclusions: Findings were made by reviewing existing guidelines and comparing them with clinical trials for colorectal cancer and herbal medicinal products. These results will be utilized in the development of the “Guideline for Clinical Trials with Herbal Medicinal Products for Colorectal Cancer”.
Methods: The development committee searched guidelines for herbal medicinal products for colorectal cancer that have already been developed. Then, clinical trials for colorectal cancer using herbal medicine were searched. The searched trials were analyzed in terms of inclusion and exclusion of participants, intervention, comparator, outcomes and trial design. Then, we compared the results of our analysis with the regulations and guidelines of the Ministry of Food and Drug Safety in order to identify the issues we will have to consider when making the “Guideline for Clinical Trials with Herbal Medicinal Products for Colorectal Cancer”. Several guidelines for anti-tumor agents and clinical trials with herbal medicinal products were searched on the national institution homepage. In addition, 12 articles were searched using a combination of the following search terms: ‘colorectal neoplasms", "herbal medicine’, "Medicine, Korean traditional", ‘Medicine, Chinese Traditional", ‘medicine, East Asian medicine’, ‘medicine, Kampo’, etc.
Results: The characteristics of participants were various, such as people with medical histories of surgeries or recurrent cancers or who complained of chemotherapy-induced side effects. The types of interventions were also various and included decoctions, powders, intravenous fluids, intraperitoneal injections and gargles. Comparators used included placebos and conventional treatments. The outcome measurements used in the studies were quality of life, symptom score, tumor response, and survival duration, etc. Safety was evaluated by recording adverse events.
Conclusions: Findings were made by reviewing existing guidelines and comparing them with clinical trials for colorectal cancer and herbal medicinal products. These results will be utilized in the development of the “Guideline for Clinical Trials with Herbal Medicinal Products for Colorectal Cancer”.
목차
서론
연구방법 및 절차
결과
고찰
결론
참고문헌
참고문헌 (61)
참고문헌 신청
National Center Information Cancer
Arnold M / 2017 / Global patterns and trends in colorectal cancer incidence and mortality / Gut 66:683~691
Global Cancer Observatory
Committee of Korean Clinical Practice Guideline for Colon and Rectal Cancer / 2012 / Korean Clilnical Practice Guideline for Colon and Rectal Cancer v1.0 / Korean Academy of Medical Sciences :21~47
National Comprehensive Cancer Network
Arnold M / 2017 / Global patterns and trends in colorectal cancer incidence and mortality / Gut 66:683~691
Global Cancer Observatory
Committee of Korean Clinical Practice Guideline for Colon and Rectal Cancer / 2012 / Korean Clilnical Practice Guideline for Colon and Rectal Cancer v1.0 / Korean Academy of Medical Sciences :21~47
National Comprehensive Cancer Network
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
폐암 한약제제 임상시험 가이드라인 개발을 위한 한약제제 무작위배정 대조군 임상시험 고찰
대한한의학회지
2019 .03
-
간암 한약제제 임상시험 가이드라인 개발을 위한 한약제제 무작위배정 대조군 임상시험 고찰
대한한방내과학회지
2019 .01
-
위암 한약제제 임상시험 가이드라인 개발을 위한 한약제제 무작위배정 대조군 임상시험 고찰
대한한의학회지
2017 .09
-
위식도역류질환 한약제제 임상시험 가이드라인 개발을 위한 관련 국내 가이드라인 분석 및 기존 한약임상시험과의 비교
대한한방내과학회지
2016 .01
-
결장직장암 치료에 대한 한의 임상 가이드라인 개발을 위한 기초연구
논문집 : 대전대학교 한의학연구소. 한의학편
2016 .01
-
한약을 사용한 암환자 대상 임상시험에서의 항암 효능 평가변수 고찰
대한예방한의학회지
2024 .04
-
건선 치료용 한약제제에 대한 임상시험 가이드라인 설명 및 제언
한방안이비인후피부과학회지
2018 .01
-
한약에 대한 N-of-1 임상시험의 현황 – 문헌 고찰
대한한의학회지
2020 .03
-
건선 한약제제 임상시험 가이드라인 개발을 위한 관련 국내외가이드라인과 기존 건선치료 한약제제 연구와의 비교
한방안이비인후피부과학회지
2016 .01
-
한약을 이용한 chemotherapy-induced peripheral neuropathy (CIPN) 치료 관련 무작위 배정 임상 시험에 대한 고찰
대한암한의학회지
2016 .01
-
Clinical Trial
대한임상종양학회 학술대회지
2015 .02
-
이원화 체계 하에서의 현대적 한약제제 분류 방안 고찰
대한한의학회지
2015 .03
-
Colorectal Cancer
대한외과학회 학술대회 초록집
2020 .11
-
Colorectal Cancer
대한외과학회 학술대회 초록집
2021 .11
-
Colorectal Cancer
대한외과학회 학술대회 초록집
2022 .11
-
Colorectal Cancer
대한외과학회 학술대회 초록집
2022 .11
-
Colorectal cancer
대한외과학회 학술대회 초록집
2015 .11
-
한약 임상시험의 특성 : 질병관리본부 임상연구정보서비스(CRIS)를 중심으로
대한한방내과학회지
2020 .01
-
암 환자 대상 한의약 임상시험에서 변증 활용에 대한 분석
대한예방한의학회지
2015 .04
-
소아 백반증의 한약 치료에 대한 최신 임상 연구 동향 - 중국 무작위 대조군 연구를 중심으로 -
대한한방소아과학회지
2021 .11
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2019-519-000766577